How often should women get pap (Papanicolau) smears?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cervical Cancer Screening Recommendations

Women should have a Pap test every 3 years for ages 21-29, and HPV and Pap co-testing every 5 years (preferred) or Pap alone every 3 years for ages 30-65, with discontinuation after age 65 if screening history is adequate. 1

Current Screening Guidelines

The most recent guidelines from major organizations provide clear recommendations for cervical cancer screening:

  • Ages 21-29: Pap test every 3 years 1
  • Ages 30-65: Preferred approach is either:
    • HPV testing alone every 5 years
    • HPV and cytology co-testing every 5 years
    • Cytology (Pap test) alone every 3 years 1

Co-testing with HPV and cytology offers several advantages:

  • Higher sensitivity for detecting precancerous lesions
  • Improved detection of preinvasive glandular lesions
  • Extended screening intervals (5 years vs. 3 years)
  • Higher negative predictive value (99-100%) 1

When to Discontinue Screening

Women can discontinue cervical cancer screening at age 65 if they meet the following criteria:

  • At least 3 consecutive negative Pap tests OR at least 2 consecutive negative HPV/Pap co-tests within the past 10 years
  • Most recent screening test performed within the last 5 years 1

Special Populations Requiring Continued Screening

Some women should continue screening beyond age 65:

  • History of cervical intraepithelial neoplasia grade 2 (CIN2) or more severe diagnosis within the past 20-25 years
  • In utero exposure to diethylstilbestrol (DES)
  • Immunocompromised status 1

Risks of Inappropriate Screening

Underscreening

An estimated 14 million women aged 21-65 have not been screened within the past 3 years 2. Groups at higher risk for underscreening include:

  • Recent immigrants to the United States
  • Women without insurance
  • Women without a usual source of healthcare 2

Overscreening

Continuing screening in women over 65 with adequate prior screening history can lead to:

  • False positive results
  • Unnecessary procedures
  • Psychological distress
  • Physical discomfort
  • No improvement in mortality or morbidity outcomes 1

For every 1000 women with a screening Pap smear, 39 had at least one downstream intervention within eight months, including seven women who underwent colposcopy and two women who had other surgical procedures 3.

Common Misconceptions and Barriers

Despite evidence-based guidelines, many women prefer more frequent screening:

  • 75% of women prefer screening at least annually
  • 69% would try to continue annual screening even against medical advice
  • Only 43% were aware of recommendations for less frequent screening
  • 50% believed less frequent screening recommendations were based on cost rather than evidence 4

Historical Context

Screening recommendations have evolved over time. The American Geriatrics Society previously recommended Pap tests every three years until age 70 5, 1. Current guidelines now focus on adequate screening history rather than a strict age cutoff.

Implementation Considerations

Healthcare providers should:

  1. Educate patients about current guidelines and the rationale behind them
  2. Address misconceptions about the basis for screening recommendations
  3. Emphasize the balance between benefits and harms of screening
  4. Document screening history carefully to support appropriate discontinuation decisions

Remember that women who have never been sexually active should still follow standard screening guidelines, starting with a Pap test at age 21, as the risk of cervical cancer is extremely low but not zero 1.

References

Guideline

Cervical Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Screening for cervical cancer: will women accept less?

The American journal of medicine, 2005

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.